SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada [Yahoo! Finance]
SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Company Research
Source: Yahoo! Finance
BOSTON and ROLLE, Switzerland March 20, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced the University of Saskatchewan (USask) as its first HRD customer in Canada . USask will implement the SOPHiA DDM™ Platform for use in its cutting-edge clinical trial, which aims to substantially improve the quality of life for ovarian cancer patients through expanded genetic testing. This is the first clinical trial in Canada designed to improve ovarian cancer treatment decisions and inspire guideline changes to increase access to advanced testing. Ovarian cancer is the most fatal gynecologic cancer; only about 45 percent of patients in Canada survive more than five years after diagnosis. The current standard for ovarian cancer tumor testing in Canada tests only for the absence or presence of a BRCA mutation; this identifies only a fraction of patients with genetic changes in their tumor. The latest trial
Show less
Read more
Impact Snapshot
Event Time:
SOPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOPH alerts
High impacting SOPHiA GENETICS SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SOPH
News
- SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024 [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024GlobeNewswire
- SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaPR Newswire
- We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth [Yahoo! Finance]Yahoo! Finance
SOPH
Earnings
- 3/5/24 - Miss
SOPH
Sec Filings
- 4/19/24 - Form 144
- 4/19/24 - Form 144
- 4/19/24 - Form 144
- SOPH's page on the SEC website